Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.
Cardiac iPSCs for Drug Discovery
Video Apr 27, 2016
The new Gibco™ One Shot™ FBS 50 mL bottle. Finally…Aliquot-free solution that reduces contamination.Video
The Gibco One Shot FBS 50 mL bottle is designed to significantly improve your results and solve myriad challenges slowing down your research. Join the aliquot-free revolution today!WATCH NOW
CellStream™ Benchtop Flow Cytometer for Sensitive Cell AnalysisVideo
The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.WATCH NOW